This is a StreetInsider.com Premium Only Page

Merck (MRK) – Major News

Feb 5, 2024 06:33 AM Merck Animal Health (MRK) Acquires Elanco’s (ELAN) Aqua Business for $1.3B Cash

Feb 1, 2024 06:31 AM Merck (MRK) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY24 Guidance

Jan 8, 2024 07:34 AM Merck (MRK) to Acquire Harpoon Therapeutics (HARP) for $23/sh Cash or $680M

Oct 26, 2023 06:32 AM Merck (MRK) Tops Q3 EPS by 18c

Aug 1, 2023 06:33 AM Merck (MRK) Tops Q2 EPS by 12c; Raises Guidance

Apr 27, 2023 06:35 AM Merck (MRK) Tops Q1 EPS by 5c; Offers FY23 Guidance

Apr 16, 2023 10:17 AM Merck (MRK) to acquire Prometheus Biosciences Inc. (RXDX) for $200/share

Feb 2, 2023 06:31 AM Merck (MRK) Tops Q4 EPS by 9c; Guides FY23 EPS Below the Street

Nov 21, 2022 06:46 AM Merck (MRK) Acquires Imago BioSciences (IMGO) for $36/sh or $1.35B

Oct 27, 2022 06:33 AM Merck (MRK) Tops Q3 EPS by 10c

Jul 28, 2022 06:37 AM Merck (MRK) Tops Q2 EPS by 19c; Raises and Narrows FY Sales Guidance, Narrows EPS

Apr 28, 2022 06:32 AM Merck (MRK) Tops Q1 EPS by 31c; Raises Outlook

Feb 3, 2022 06:32 AM Merck (MRK) Tops Q4 EPS by 24c

Oct 28, 2021 06:35 AM Merck (MRK) Tops Q3 EPS by 20c, Offers FY Guidance

Sep 30, 2021 06:46 AM Merck (MRK) to Acquire Acceleron Pharma (XLRN) for $180 Per Share in $11.5 Billion Deal

Jul 29, 2021 06:49 AM Merck (MRK) Misses Q2 EPS by 17c, Guidance Comes in Light

Apr 29, 2021 06:32 AM Merck (MRK) Misses Q1 EPS by 23c, Offers FY Guidance

Feb 4, 2021 06:47 AM Merck (MRK) Misses Q4 EPS by 6c, FY Guidance Tops Views

Oct 27, 2020 06:49 AM Merck (MRK) Tops Q3 EPS by 31c, Revenues Beat; Narrows & Raises FY20 Non-GAAP EPS Guidance Above Consensus, Provides FY20 Revs. Outlook

Jul 31, 2020 06:46 AM Merck (MRK) Tops Q2 EPS by 33c, Updates FY Guidance

Apr 28, 2020 06:48 AM Merck (MRK) Tops Q1 EPS by 16c, Revenues Beat; Lowers FY20 EPS/Revenue Guidance Below Consensus

Feb 5, 2020 06:49 AM Merck (MRK) Tops Q4 EPS by 1c, Offers FY Guidance

Feb 5, 2020 06:46 AM Merck (MRK) Announces Spinoff of Women�s Health, Trusted Legacy Brands and Biosimilars Products

Dec 9, 2019 06:46 AM Merck (MRK) to Acquire ArQule (ARQL) for $20/Share in $2.7B Deal

Oct 29, 2019 06:47 AM Merck (MRK) Tops Q3 EPS by 27c, Revenues Beat; Narrows & Raises FY19 EPS/Revenue Above Consensus

Jul 30, 2019 06:47 AM Merck (MRK) Tops Q2 EPS by 14c, Raises FY Guidance

Apr 30, 2019 06:47 AM Merck (MRK) Tops Q1 EPS by 17c, Updates FY Guidance

Feb 1, 2019 06:47 AM Merck (MRK) Tops Q4 EPS by 1c, Offers FY Guidance

Oct 25, 2018 06:46 AM Merck (MRK) Tops Q3 EPS by 7c, Raises Dividend and Increases Buyback by $10 Billion

Sep 26, 2018 06:45 AM Merck (MRK) Rescinds Mandatory CEO Retirement Policy

Jul 27, 2018 06:54 AM Merck (MRK) Tops Q2 EPS by 3c, Updates FY Guidance

May 1, 2018 06:46 AM Merck (MRK) Tops Q1 EPS by 5c, Updates FY Guidance

Feb 2, 2018 06:47 AM Merck (MRK) Tops Q4 EPS by 4c, Offers FY Guidance

Oct 27, 2017 06:49 AM Merck (MRK) Tops Q3 EPS by 8c, Lifts FY EPS Gudiance

Jul 28, 2017 06:47 AM Merck (MRK) Tops Q2 EPS by 14c

May 2, 2017 06:46 AM Merck (MRK) Tops Q1 EPS by 5c; Raises Outlook

Feb 23, 2017 05:21 PM Merck (MRK) to Take $2.9B Pre-Tax Impairment Charge on HCV Drug

Feb 2, 2017 06:47 AM Merck (MRK) Reports In-Line Q4; Guides In-Line

Oct 25, 2016 06:46 AM Merck (MRK) Tops Q3 EPS by 8c; Narrows FY16 Outlook

Aug 2, 2016 02:49 PM Biogen (BIIB) Draws Takeover Interest from Allergan (AGN), Merck (MRK) - DJ

Jul 29, 2016 06:46 AM Merck (MRK) Tops Q2 EPS by 2c; Updates FY16 EPS Outlook

May 5, 2016 06:45 AM Merck (MRK) Tops Q1 EPS by 4c

Feb 3, 2016 06:45 AM Merck (MRK) Tops Q4 EPS by 2c

Oct 27, 2015 06:47 AM Merck (MRK) Tops Q3 EPS by 4c; Lifts FY15 EPS Outlook

Jul 28, 2015 07:02 AM Merck (MRK) Tops Q2 EPS by 5c; Narrows and Raise FY15 EPS Outlook

Apr 28, 2015 07:02 AM Merck (MRK) Tops Q1 EPS by 11c; Bumps Non-GAAP FY15 Outlook

Feb 4, 2015 07:03 AM Merck (MRK) Tops Q4 EPS by 1c

Dec 22, 2014 07:26 AM FDA Approves Cubist Pharma's (CBST) ZERBAXA

Dec 8, 2014 07:02 AM Merck (MRK) to Acquire Cubist Pharma (CBST) for $102/Share

Dec 8, 2014 07:02 AM Merck (MRK) to Acquire Cubist Pharma (CBST) for $102/Share; Deal Valued ~$9.5B